News | March 25, 2022
CHMP recommends EU approval of Roche’s new combination treatment for large B-cell lymphoma
Recommendation is based on pivotal data from the phase III POLARIX study
Recommendation is based on pivotal data from the phase III POLARIX study
#BeTheChangeForTB is a public awareness initiative under the Corporate TB Pledge and aims to create a cadre of Youth Changemakers who can act as catalysts of change to help eliminate TB from India
Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025
She joined Trivitron Healthcare in 1999 and has held several positions in the organisation
Building the future of food in the birthplace of cell-cultured milk
Twelve abstracts and two late-breaking presentations demonstrate AbbVie and Allergan Aesthetics' shared commitment to advancing research across a spectrum of dermatologic conditions and aesthetic indications
Sputnik Light is the first component of Sputnik V
The Karnataka Health Promotion Trust held a day-long session in New Delhi to address health care challenges
To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India
The investment will accelerate the overall Sarclisa development program
Subscribe To Our Newsletter & Stay Updated
